Literature DB >> 1339180

Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.

F Y Gan1, M S Gesell, J A Moshier, M Alousi, G D Luk.   

Abstract

Ornithine decarboxylase (ODC) has been shown by biochemical analysis, to be important for cell proliferation and carcinogenesis in a variety of tissues, including the liver. We detected messenger RNA (mRNA) specific for the enzyme ODC in 18 patients with hepatocellular carcinoma by an in situ hybridization technique using a radiolabelled ODC probe on formalin-fixed liver specimens. Adjacent uninvolved liver tissues were used as controls. Among the adjacent uninvolved liver tissues, five showed evidence of cirrhosis. Poorly differentiated hepatocellular carcinoma has significantly higher levels of ODC mRNA than does well-differentiated hepatocellular carcinoma, which in turn has a significantly higher ODC mRNA level than adjacent uninvolved liver tissues; tissues showing evidence of cirrhosis, on the other hand, had a significantly lower ODC mRNA level than adjacent uninvolved liver tissue. This pattern of ODC gene expression in hepatocellular carcinoma is similar to the pattern of expression of other oncogenes in liver tumours. The quantitative detection of ODC mRNA in hepatocellular carcinoma by in situ hybridization may help elucidate the potential role of ODC in hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339180

Source DB:  PubMed          Journal:  Epithelial Cell Biol        ISSN: 0940-9912


  2 in total

1.  Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis.

Authors:  T Matsui; T Akahoshi; R Namai; A Hashimoto; Y Kurihara; M Rana; A Nishimura; H Endo; H Kitasato; S Kawai; K Takagishi; H Kondo
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

2.  Up-regulation of prostaglandin E receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis.

Authors:  Y Kurihara; H Endo; T Akahoshi; H Kondo
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.